Company Filing History:
Years Active: 2023-2025
Title: Todd Verdoorn: Innovator in Tissue Kallikrein Research
Introduction
Todd Verdoorn is a notable inventor based in Minnetonka, MN (US). He has made significant contributions to the field of biomedical research, particularly in the development of dosage forms for tissue kallikrein-1 polypeptides. With a total of 3 patents to his name, Verdoorn's work has the potential to impact treatments for various medical conditions.
Latest Patents
One of Todd Verdoorn's latest patents focuses on dosage forms of tissue kallikrein-1 (KLK1) polypeptides. This patent provides dosage forms that contain a total KLK1 polypeptide dosage ranging from about 0.1 μg/kg to about 10.0 μg/kg. The patent includes both subcutaneous and intravenous dosage forms. Additionally, it outlines related devices and methods for treating ischemic and hemorrhagic conditions.
Career Highlights
Throughout his career, Todd Verdoorn has worked with several companies, including Diamedica Inc. and Diamedica USA Inc. His experience in these organizations has contributed to his expertise in the field of tissue kallikrein research.
Collaborations
Todd has collaborated with various professionals in his field, including Rick Pauls. These collaborations have likely enhanced his research and development efforts.
Conclusion
Todd Verdoorn is a distinguished inventor whose work in tissue kallikrein research is paving the way for innovative medical treatments. His contributions are significant in advancing the understanding and application of KLK1 polypeptides in clinical settings.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.